In addition, post hoc analyses of the PROGRESSA (Metabolic Determinants of the Progression of Aortic Stenosis) trial5 found that apoB/apoA‐I was associated with faster hemodynamic progression in patients with mild to moderate AVS. Here, APOB is linked to aortic stenosis.